Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 475

Pluristem Therapeutics

Pluristem and Tnuva celebrated their partnership at NASDAQ in New York on Monday. (Courtesy of Nasdaq, inc.)
March 30, 2022, 8:06 pm
Israeli companies at NASDAQ want to bring lab-grown meat to the masses
Pluristem Therapeutics, Tnuva join race to create products from animal cells, using tech they say is more sustainable than natural methods
By Jacob Henry
Illustrative: A scientist holds a petri dish in a laboratory with a sample of cultured meat. (Liudmila Chernetska/istock via Getty Images)
January 11, 2022, 3:50 pm
Tnuva beefs up food tech operations with new cultured meat venture
Israeli food company partners with biotech firm Pluristem Therapeutics to launch lab-grown meat, aiming at a quick trip to market, followed by animal-free dairy, fish
By Ricky Ben-David
The bioreactor where Pluristem produces cells for its treatment (David Garb)
April 16, 2020, 9:19 pm
Israeli firm hopeful as it starts treating COVID-19 patients with placenta cells
‘I think this will have a huge impact,’ CEO of Pluristem says, but public health expert cautions: ‘I don’t have any feeling this is going to work’
By Nathan Jeffay
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
June 26, 2018, 3:38 pm
Study shows placenta treatment effective against radiation sickness
Haifa-based Pluristem has been working with researchers in Fukushima, the site of nuclear meltdowns in 2011, to treat acute radiation syndrome
By ToI Staff
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
October 25, 2016, 4:40 pm
Israel’s Pluristem to get $30m Chinese investment
Company that produces patented cells from placentas signs term sheet with Innovative Medical Management
By Shoshanna Solomon
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
December 4, 2015, 2:12 pm
Japan turns to Israeli tech to treat radiation disease
Pluristem’s stem-cell technology may hold cure for victims affected by the 2011 Fukushima nuclear disaster
By David Shamah
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
July 29, 2015, 6:11 pm
Israeli placenta-derived cells get nod from top researchers
Pluristem’s platform, which delivers a ‘cocktail of therapeutic proteins,’ is seen to be useful for a slew of diseases
By David Shamah
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
March 4, 2015, 5:34 pm
Israeli radiation disease treatment passes major hurdle
The NIH is relying on Pluristem’s placenta-based stem cell treatment as a worst-case insurance policy
By David Shamah
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
January 13, 2015, 7:14 pm
Study: Placenta cells could reverse stroke damage
Israeli biotech company Pluristem says its PLX technology could potentially treat and repair damaged nerves
By David Shamah
Pluristem workers process placenta for the company's cell-based therapy products (Courtesy)
October 27, 2014, 6:57 pm
Israeli cells could save US from nuclear health disaster
Pluristem’s off-the-shelf placenta-based cell therapies are being tested by a top US agency – just in case
By David Shamah
A preservation lab in a hospital used for stem cell research (Photo credit: Margalit Slovin/Flash90)
March 19, 2014, 5:52 pm
Biotech start-up reportedly on verge of $600m deal
Gamida, a stem-cell technology developer, is just one example of Israel’s biotechnology prowess, say experts
By David Shamah
Pluristem's first bioreactor for the enrichment of mesenchymal adherent stromal cells (ASCs) from cord blood (Photo credit: Courtesy)
March 10, 2014, 6:02 pm
FDA approves Israel-developed stem cell ‘factory’ for research
Pluristem is moving into mass-production of its placenta-based muscle repair system
By David Shamah
From the WebDecember 17, 2013, 12:21 pm
Korea’s Cha, Israel’s Pluristem in mutual share investment
Reuters: A South Korean biotech firm and an Israel company in the stem cell research field ‘trade’ shares worth over $10 million
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.